Recce Pharmaceuticals inks new patent for flagship drug in Israel Posted on April 3, 2024September 25, 2024 by recce_com Recce Pharmaceuticals inks new patent for flagship drug in Israel
Recce reaches testing milestone for UTI, Uroseptis antibiotic Posted on March 22, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Uroseptis antibiotic
Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis Posted on March 18, 2024September 25, 2024 by recce_com Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis
Recce reaches testing milestone for UTI, Urosepsis antibiotic Posted on March 17, 2024September 25, 2024 by recce_com Recce reaches testing milestone for UTI, Urosepsis antibiotic
Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial
Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital
Biotech around the World: The Low-Down on the Land Down Under Posted on March 3, 2024September 25, 2024 by recce_com Biotech around the World: The Low-Down on the Land Down Under
BioBoss Podcast – CEO James Graham Posted on February 29, 2024September 25, 2024 by recce_com BioBoss Podcast – CEO James Graham
Recce Pharmaceuticals leads the way in collaborative Anti-Infective research Posted on February 27, 2024September 25, 2024 by recce_com Recce Pharmaceuticals leads the way in collaborative Anti-Infective research
Recce Pharmaceuticals wins safety approval to expand wound infection trial Posted on February 26, 2024September 25, 2024 by recce_com Recce Pharmaceuticals wins safety approval to expand wound infection trial
